JP2025514774A5 - - Google Patents
Info
- Publication number
- JP2025514774A5 JP2025514774A5 JP2024561891A JP2024561891A JP2025514774A5 JP 2025514774 A5 JP2025514774 A5 JP 2025514774A5 JP 2024561891 A JP2024561891 A JP 2024561891A JP 2024561891 A JP2024561891 A JP 2024561891A JP 2025514774 A5 JP2025514774 A5 JP 2025514774A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- nucleic acid
- human
- pharmaceutical composition
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263332606P | 2022-04-19 | 2022-04-19 | |
| US63/332,606 | 2022-04-19 | ||
| PCT/US2023/065898 WO2023205644A1 (en) | 2022-04-19 | 2023-04-18 | Modified western equine encephalitis viruses and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025514774A JP2025514774A (ja) | 2025-05-09 |
| JP2025514774A5 true JP2025514774A5 (https=) | 2026-04-23 |
Family
ID=88420660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024561891A Pending JP2025514774A (ja) | 2022-04-19 | 2023-04-18 | 改変西部ウマ脳炎ウイルス及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250257329A1 (https=) |
| EP (1) | EP4511497A4 (https=) |
| JP (1) | JP2025514774A (https=) |
| KR (1) | KR20250024759A (https=) |
| CN (1) | CN119301261A (https=) |
| AU (1) | AU2023256639A1 (https=) |
| CA (1) | CA3256333A1 (https=) |
| IL (1) | IL316351A (https=) |
| WO (1) | WO2023205644A1 (https=) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6054566A (en) * | 1988-02-26 | 2000-04-25 | Biosource Technologies, Inc. | Recombinant animal viral nucleic acids |
| US6261570B1 (en) * | 1997-05-20 | 2001-07-17 | The United States Of America As Represented By The Secretary Of The Army | Live attenuated virus vaccines for western equine encephalitis virus, eastern equine encephalitis virus, and venezuelan equine encephalitis virus IE and IIIA variants |
| WO2020076775A1 (en) * | 2018-10-08 | 2020-04-16 | Janssen Pharmaceuticals, Inc. | Alphavirus-based replicons for administration of biotherapeutics |
| AU2021236068A1 (en) * | 2020-03-09 | 2022-10-06 | Arcturus Therapeutics, Inc. | Compositions and methods for inducing immune responses |
| US20230024133A1 (en) * | 2020-07-06 | 2023-01-26 | Janssen Biotech, Inc. | Prostate Neoantigens And Their Uses |
| US20230398200A1 (en) * | 2020-07-31 | 2023-12-14 | Replicate Bioscience, Inc. | Modified chikungunya viruses and sindbis viruses and uses thereof |
-
2023
- 2023-04-18 EP EP23792709.0A patent/EP4511497A4/en active Pending
- 2023-04-18 JP JP2024561891A patent/JP2025514774A/ja active Pending
- 2023-04-18 CN CN202380043278.4A patent/CN119301261A/zh active Pending
- 2023-04-18 IL IL316351A patent/IL316351A/en unknown
- 2023-04-18 US US18/858,163 patent/US20250257329A1/en active Pending
- 2023-04-18 CA CA3256333A patent/CA3256333A1/en active Pending
- 2023-04-18 WO PCT/US2023/065898 patent/WO2023205644A1/en not_active Ceased
- 2023-04-18 AU AU2023256639A patent/AU2023256639A1/en active Pending
- 2023-04-18 KR KR1020247037974A patent/KR20250024759A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7416443B2 (ja) | 高形質導入効率ｒＡＡＶベクター、組成物、および使用方法 | |
| US20220016237A1 (en) | Rna replicon vaccines against hbv | |
| CN105849270B (zh) | 用于病毒疗法的新型流感病毒载体 | |
| JP2024527345A5 (https=) | ||
| US20230398200A1 (en) | Modified chikungunya viruses and sindbis viruses and uses thereof | |
| EP2977457B1 (en) | Idna vaccines and methods for using the same | |
| US20240327865A1 (en) | Modified eastern equine encephalitis viruses, self-replicating rna constructs, and uses thereof | |
| US20240400619A1 (en) | Modified alphaviruses with heterologous nonstructural proteins | |
| JP2025514774A5 (https=) | ||
| JP2024535729A5 (https=) | ||
| CN118108860B (zh) | 一种基于FcRn可提高细胞免疫水平的重组疫苗及应用 | |
| CN116904489B (zh) | 一种鸭坦布苏病毒核酸疫苗及应用 | |
| IL316351A (en) | Modified western equine encephalitis viruses and uses thereof | |
| CN101120086A (zh) | 用于肿瘤治疗的黄病毒复制子结构 | |
| US12558417B2 (en) | Hepatitis A virus preparation method and hepatitis A virus prepared according to method | |
| JP2025522967A (ja) | 連結ペプチド、連結ペプチドを含む血液凝固ｖｉｉｉ因子タンパク質又はその変異体及びその用途 | |
| JP2002544236A (ja) | 組換えパラポックスウイルスに基づくとりわけ肝の慢性ウイルス感染症ならびに炎症性、変性性および増殖性疾患ならびに癌のための器官、組織および細胞特異的免疫治療薬 | |
| WO2025180455A1 (en) | A circular rna vaccine against herpes zoster virus and the use thereof | |
| WO2025157249A1 (zh) | 一种自复制rna及其用途 | |
| JP2024542613A (ja) | Ｉｌ－１２及びｉｌ－１ｒａの発現のための組成物と方法 | |
| WO2024219994A1 (ru) | Экспрессионный вектор на основе аденовируса человека 19 серотипа и способ его применения | |
| HK40091626A (zh) | 针对hbv的rna复制子疫苗 | |
| EA048601B1 (ru) | Экспрессионный вектор на основе аденовируса человека 19 серотипа и способ его применения | |
| JP2022536474A (ja) | アストロウイルスレプリコンの方法および組成物 | |
| HK1116831A (en) | Flavivirus replicon constructs for tumour therapy |